This study was aimed to investigate the role of
eicosapentaenoic acid monoacylglyceride (
MAG-EPA) and
17,18-epoxyeicosatetraenoic acid (17,18-EpETE) on the regulation of contractile reactivity and
nuclear protein expression in 72-h-cultured and TNF-α-treated guinea pig tracheal rings. Tension measurements performed on native tissues demonstrated that the
cytochrome P-450 epoxygenase (CYP450)-dependent EPA metabolite,
17,18-EpETE, displayed a higher potency than
MAG-EPA in inhibiting U-46619-induced tone.
Calphostin C (a PKC inhibitor), whether in association or not with
MAG-EPA or
17,18-EpETE, had no further effect, while
17,18-EpETE and
Y-27632 (a
Rho kinase inhibitor) yielded additive effects. Of note,
MAG-EPA and
17,18-EpETE pre-treatments normalized the contractile responses to broncho-constrictive agents in 72-h-cultured trachea. The enhanced expression of TNF-α, P-p65-nuclear factor kappaB (NF)-κB, c-fos and c-Jun in 72-h-cultured tissues likely contributed to the hyperresponsiveness. β-
Escin-permeabilized preparations demonstrated that
17,18-EpETE abolished Ca(2+)
hypersensitivity, suggesting a blunting of PKC and/or
Rho kinase activation. Lastly, activation of NF-κB and activating protein-1 (AP-1) signalling by exogenous TNF-α markedly increased the contractile response to MCh, through an increase in 17-kDa PKC-potentiated inhibitory
protein of PP1 (CPI-17) phosphorylation and IκBα degradation. Dual incubation of
17,18-EpETE with
calphostin C or
Y-27632 induced cumulative inhibitory effects on MCh responses in TNF-α-incubated tracheal rings.
17,18-EpETE also reduced the detection level of P-p65-NF-κB and
AP-1 subunits. The present data provide evidence that
MAG-EPA, through its bioactive metabolite, represents a prospective pharmacological target in
respiratory diseases.